Pancreatic expression of interleukin-4 abrogates insulitis and autoimmune diabetes in nonobese diabetic (NOD) mice

Journal of Experimental Medicine

Volumn 184, Issue 3, 1996, Pages 1093-1099

  Mueller, Régula ^a,b   Krahl, Troy ^a   Sarvetnick, Nora ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b CVN 10 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 4;

ANIMAL CELL; ARTICLE; AUTOIMMUNITY; CELL SPECIFICITY; DIABETES MELLITUS; DIABETOGENESIS; GENE EXPRESSION REGULATION; GENE INDUCTION; IMMUNE RESPONSE; IMMUNOREACTIVITY; INSULITIS; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; SPLEEN CELL; TRANSGENE;

EID: 0029838995     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.184.3.1093     Document Type: Article

References (39)

1. Kikutani, H., and S. Makino. 1992. The murine autoimmune diabetes model: NOD and related strains. Adv. Illuminai. 51: 285-322.
2. Signore, A., P. Pozzilli, E.A.M. Gale, D. Andreani, and P.C.L. Beverly. 1989. The natural history of lymphocyte subsets infiltrating the pancreas of NOD mice. Diabctologia. 32:282-289.
3. Harada, M., and S. Makino. 1986. Suppression of overt diabetes in NOD mice by antithymocyte serum or anti-Thyl.2 antibody. Expérimenta Animais. 35:501-506.
4. Koike, T., Y. Itoh, T. Ishi, I. Ito, K. Takabayashi, N. Maruyama, H. Tomioka, and S. Yoshida. 1987. Preventive effect of monoclonal anti-L3T4 antibody on development of diabetes in NOD mice. Diabetes. 36:539-541.
5. Hayward, A.R., and M. Schreiber. 1989. Neonatal injection of CD3 antibody into nonobese diabetic mice reduces incidence of insulitis and diabetes. J. Iiiiiinnwl. 143:1555-1559.
6. Seinpe, P., P. Bedossa, M.-F. Richard, M.-C. Villa, J.-F. Bach, and C. Boitard. 1991. Anti-a/ T cell receptor monoclonal antibody provides efficient therapy for autoimmune diabetes in nonobese diabetic (NOD) mice. Enr.J. Illuminai. 21:1163-1169.
7. Wicker, L.S., BJ. Miller, and Y. Müllen. 1986. Transfer of autoimmune diabetes mellitus with splenocytes from nonobese diabetic (NOD) mice. Diabetes. 35:855-860.
8. Christianson, S.W., L.D. Shultz, and E.H. Leiter. 1993. Adoptive transfer of diabetes into immunodeficient NODscid/scid mice. Diabetes. 42:44-55.
9. Mosmann, T.R., and R.L. Coffman. 1989. Thl- and Th2cells: different patterns of lymphokine secretion lead to differ-ent functional properties. Anini. Rev. Iiiinninol. 7:145-173.
10. Erard, F., M.T. Wild, J.A. Garcia Sanz, and G. Le Gros. 1993. Switch of CDS T cells to noncytolytic CD8~CD4~ cells that make Th2 cytokines and help B cells. Science (Wash. DC). 260:1802-1805.
11. Croft, M., L. Carter, S. Swain, and R.W. Dutton. 1994. Generation of polarized antigen-specific CDS effector populations: reciprocal action of interleukin (IL)-4 and 1L-12 in promoting type 2 versus type 1 cytokine profiles. J. Exp. Mcd. 180:1715-1728.
12. Sad, S., R. Marcotte, and T. Mosmann. 1995. Cytokineinduced differentiation of precursor mouse CDS1 T cells into cytotoxic CD8+ T cells secreting Thl or Th2 cytokines. Immunity. 2:271-279.
13. LeGros, G., S.Z. Den-Sasson, R. Seder, F.D. Finkelman, and W.E. Paul. 1990. Generation of interleukin-4 (IL-4)-producing cells in vivo and in vitro: IL-2 and IL-4 required for in vitro generation of IL-4-producing cells. J. Exp. Mcd. 172: 921-929.
14. Rabinovitch, A. 1994. Immunoregulatory and cytokine imbalances in the pathogenesis of 1DDM. Diabetes. 43:613-621.
15. Healey, D., P. Ozegbe, S. Arden, P. Chandler, J. Hutton, and A. Cooke. 1995. In vivo activity and in vitro specificity of CD4+ Thl and Th2 cells derived from the spleens of diabetic NOD micej. Clin. Invest. 95:2979-2985.
16. Katz, J.D., C. Denoist, and D. Mathis. 1995. T helper cell subsets in insulin-dependent diabetes. Science (Wash. DC). 268:1185-1188.
17. Sarvetnick, N., D. Liggitt, S.L. Pitts, S.E. Hansen, and T.A. Stewart. 1988. Insulin-dependent diabetes mellitus induced in transgenic mice by ectopic expression of class II MHC and interferon-gamma. Cell. 52:773-782.
18. Lee, M.-S., L. Wogensen, J. Shizuru, M.B.A. Oldstone, and N. Sarvetnick. 1994. Pancreatic islet production of niurine interleukin-10 does not inhibit immune-mediated tissue destruction. J. Clin. Imrst. 93:1332-1338.
19. Lewis, D.D., C.C. Yu, K.A. Forbush, J. Carpenter, T.A. Sato, A. Grossman, D.H. Liggitt, and R.P. Perlmutter. 1991. Interleukin-4 expressed in situ selectively alters thymocyte development./ Evp. Mcd. 173:89-100.
20. Wogensen, L., X. Huang, and N. Sarvetnick. 1993. Leukocyte extravasation into the pancreatic tissue in transgenic mice expressing interleukin-10 in the islets of Langerhans. J. Exp. Mcd. 178:175-185.
21. Lee, M.-S., D. Gu, S. Curriden, M. Arnush, T. Krahl, D. Gurushanthaiah, C.B. Wilson, D.L. Loskutoff, H. Fox, and N. Sarvetnick. 1995. Accumulation of extracellular matrix and developmental dysregulation in the pancreas by transgenic production ofTGF-l. Am.J. Pathol 147:42-52.
22. Croft, M., and S.L. Swain. 1995. Recently activated naive CD4 T cells can help resting B cells, and can produce sufficient autocrine IL-4 to drive differentiation of secretion of T helper 2-type cytokines. J. Iiiinninol. 154:4269-4282.
23. Bradley, L.M., D.D. Duncan, K. Yoshimoto, and S.L. Swain. 1993. Memory effectors: a potent, IL-4 secreting helper T cell population that develops in vivo after restimulation with antigen./ Immunol. 150:3119-3130.
24. Heath, W.R., J. Allison, M.W. Hoffmann, G. Schoenrich, G. Haemmerling, B. Arnold, andJ.F.A.P. Miller. 1992. Autoimmune diabetes as a consequence of locally produced interleukin-2. Nature (Land.). 359:547-549.
25. Von Herrath, M.G., J. Dockter, and M.B.A. Oldstone. 1994. How virus induces a rapid or slow onset insulin-dependent diabetes niellitus in a transgenic model. Immunity. 1:231-242.
26. Wang, T., 13. Singh, G.L. Warnock, and R.V. Rajotte. 1992. Prevention of recurrence of IDDM in islet-transplanted diabetic NOD mice by adjuvant immunotherapy. Diabetes. 41: 114-117.
27. Daekkeskov, S., J. Aanstoot H, S. Christgau, A. Reetz, M. Solimena, M. Cascalho, F. Folli, H. Richter-Olesen, P. DeCamilli, and P. DeCamilli. 1990. Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature (Loud.). 347:151-156.
28. Tisch, R., X.-D. Yang, S.M. Singer, R.S. Liblau, L. Fugger, and H.O. McDevitt. 1993. Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice. Nature (Loud.). 366:72-75.
29. Kaufman, D.L., M. Clare-Salzler, J. Tian, T. Forsthuber, G.S.P. Ting, P. Robinson, M.A. Atkinson, E.E. Sercarz, AJ. Tobin, and P.V. Lehmann. 1993. Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulindependent diabetes. Nature (Loud.). 366:69-72.
30. Rapoport, M.J., A. Jaramillo, D.V. Serreze, E.H. Leiter, P. Cyopick,J.S. Danska, and T.L. Delovitch. 1993. Interleukin4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice. J. E.\p. Hied. 178:87-99.
31. Roeken, M., J. Urban, and E.M. Shevach. 1994. Antigenspecific activation, tolerization, and reactivation of the interleukin-4 pathway in vivo. J. Exp. Med. 179:1885-1893.
32. Hurdlings, P.R., E. Simpson, L.A. O'Reilly, T. Lund, H. Waldmann, and A. Cooke. 1990. The involvement of Ly2+ T-cells in -cell destruction. J. Aiitoiiiiiiiiin. 3:101-109.
33. Wicker, L.S., E.H. Leiter, J.A. Todd, RJ. Renjilian, E. Peterson, P.A. Fischer, P.L. Podolin, M. Zijlstra, R.Jaenisch, and L.B. Peterson. 1994. 2-microglobulin-deficient NOD mice do not develop insulitis and diabetes. Diabetes. 43:500504.
34. Serreze, D.V., E.H. Leiter, GJ. Christianson, D. Greiner, and D.C. Roopenian. 1994. Major histocompatibility complex class I-deficient NOD-B2;iinuU mice are diabetes and insulitis resistant. Diabetes. 43:505-509.
35. Sumida, T., M. Furukawa, A. Sakamoto, T. Namekawa, T. Maeda, M. Zijlstra, I. hvamoto, T. Kioke, S. Yoshida, H. Tomioka, and M. Taniguchi. 1994. Prevention of insulitis and diabetes in 2-microglobulin-deficient non-obese diabetic mice. Int. Iiiiiiiiinal. 6:1445-1449.
36. Sad, S., and T.R. Mosmann. 1995. Interleukin (lL)-4, in the absence of antigen stimulation, induces an anergy-like state in differentiated CD8+ TC1 cells: loss of IL-2 synthesis and autonomous proliferation but retention of cytotoxicity and synthesis of other cytokines.J. Exp. Mcd. 182:1505-1515.
37. Liew, F.Y., Y. Li, A. Severn, S. Millott, J. Schmidt, M. Salter, and S. Moncada. 1991. A possible novel pathway of regulation by murine T helper type-2 (Th2) cells of a Thl cell activity via the modulation of the induction of nitric oxide synthase on macrophages. Enr.J. Iiiiiiiiinol. 21:2489-2494.
38. Sands, W.A., V. Bulut, A. Severn, D. Xu, and F.Y. Liew. 1994. Inhibition of nitric oxide synthesis by interleukin-4 may involve inhibiting the activation of protein kinase C epsilon. Enr.J. Iinnninol. 24:2345-2350.
39. Gautam, S., J.M. Tebo, and T.A. Hamilton. 1992. IL-4 suppresses cytokine gene expression induced by IFN-gamma and/or IL-2 in murine peritoneal macrophages. J. Iinnninol. 148:1725-1730.